Our Recommendations
- Clinical features and management of human monkeypox: a retrospective observational study in the UK (2022)
- Hinweise zur Therapie von Affenpocken (2022)
- Laboratory testing for the monkeypox virus (2022)
- Surveillance, case investigation and contact tracing for monkeypox: interim guidance 24 June 2022 (2022)
- Monkeypox outbreak toolbox (2022)
New Publications
- Australian guidelines for the clinical care of people with MPX (2022)
- Vaccines and immunization for monkeypox: Interim guidance, 16 November 2022 (2022)
- Monkeypox outbreak toolbox (2022)
- Clinical features and management of human monkeypox: a retrospective observational study in the UK (2022)
- Surveillance, case investigation and contact tracing for monkeypox: interim guidance 24 June 2022 (2022)
Filter
34
Featured
Recommendations
8
New Publications
3
Language
Document type
Guidelines
22
Studies & Reports
4
Fact sheets
4
Resource Platforms
3
Training Material
1
Countries / Regions
Nigeria
5
Germany
2
Mozambique
1
Congo, Democratic Republic of
1
United Kingdom
1
South Africa
1
Brazil
1
Angola
1
Authors & Publishers
Publication Years
Category
MPOX - Monkeypox
20
Guidelines
3
x MEDBOX Issue Brief & Annual Reports x
1
General Guidelines
1
Virology
1
Toolboxes
MPOX - Monkeypox
34
MOPX - Monkeypox
3
MPOX -Monkeybox Prevention & Control
3
Surveillance
1
Laboratory & Sampling
1
Risk Communication & Community Engagement
1
Other Resources
1
Surveillance, case investigation and contact tracing for monkeypox: interim guidance 24 June 2022
recommended
The overall goal of surveillance, case investigation and contact tracing in this context is to stop human-to-human transmission to control the outbreak. The key objectives of surveillance and case investigation are to rapidly identify cases and clusters in order to provide optimal clinical care; to ...
The goal of the global outbreak response for monkeypox is to stop human-to-human transmission of monkeypox, with a priority focus on communities at high risk of exposure which may differ according to context, and to effectively use strong public health measures to prevent onward spread of the diseas...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
The Interim Guidance for Risk Communication and Community Engagement (RCCE) outlines recommendations, considerations and methods to raise awareness, manage risk perception, maintain trust and proactively support people at risk to make informed decisions to protect themselves and others from monkeypo...
Presentation
MEDBOX Issue Brief no.22, updated August 9, 2022
In a retrospective review of hospital records of 40 human monkeypox cases from Nigeria, the majority developed fever and self-limiting vesiculopustular skin eruptions. Five deaths
were reported. Compared to human immunodeficiency virus (HIV)–negative cases, HIV type 1–coinfected cases had more ...
South Africa has recorded its first case of monkeypox today, 23 June 2022. The Minister of
Health Dr. Joe Phaahla explained that he received a report from the National Health
Laboratory Services’ CEO that they have confirmed through laboratory tests the first case of
monkeypox in South Africa. ...
In September, 2017, human monkeypox re-emerged in Nigeria, 39 years after the last reported case. We aimed to describe the clinical and epidemiological features of the 2017–18 human monkeypox outbreak in Nigeria.
This document summarises the available data on MVA-BN (Imvanex) including from previous
experience of use of this vaccine in contacts of monkeypox cases in the UK and details the
current advice of an expert working group (see Appendix 1 for details) on the use of this vaccine
for pre- and post-ex...
WHO invites Member States, health facilities and other entities to participate in the global effort to collect anonymized clinical data relating to suspected or confirmed cases of monkeypox and contribute data to the WHO Global Clinical Platform.
WHO has developed a clinical characterization case ...
Informationsplattform rund um Affenpocken
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
21 juillet 2022
21 July 2022. The Rapid Core CRF is designed to collect data obtained through examination, interview and review of
hospital or clinic notes of patients with suspected, probable, or confirmed monkeypox infection. Data
may be collected prospectively or retrospectively. The data collection period is ...
Monkeypox content collection
recommended
The Lancet Group publishes the latest monkeypox-related content across epidemiology, treatments, and much more. Here you can explore monkeypox content published across all Lancet journals and content types. All of our monkeypox content is free to access.
Updated August 2022
